Lorca, R.; Aparicio, A.; Gómez, J.; Álvarez-Velasco, R.; Pascual, I.; Avanzas, P.; González-Urbistondo, F.; Alen, A.; Vázquez-Coto, D.; González-Fernández, M.;
et al. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence. J. Clin. Med. 2023, 12, 2133.
https://doi.org/10.3390/jcm12062133
AMA Style
Lorca R, Aparicio A, Gómez J, Álvarez-Velasco R, Pascual I, Avanzas P, González-Urbistondo F, Alen A, Vázquez-Coto D, González-Fernández M,
et al. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence. Journal of Clinical Medicine. 2023; 12(6):2133.
https://doi.org/10.3390/jcm12062133
Chicago/Turabian Style
Lorca, Rebeca, Andrea Aparicio, Juan Gómez, Rut Álvarez-Velasco, Isaac Pascual, Pablo Avanzas, Francisco González-Urbistondo, Alberto Alen, Daniel Vázquez-Coto, Mar González-Fernández,
and et al. 2023. "Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence" Journal of Clinical Medicine 12, no. 6: 2133.
https://doi.org/10.3390/jcm12062133
APA Style
Lorca, R., Aparicio, A., Gómez, J., Álvarez-Velasco, R., Pascual, I., Avanzas, P., González-Urbistondo, F., Alen, A., Vázquez-Coto, D., González-Fernández, M., García-Lago, C., Cuesta-Llavona, E., Morís, C., & Coto, E.
(2023). Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence. Journal of Clinical Medicine, 12(6), 2133.
https://doi.org/10.3390/jcm12062133
